196.00
196.00
Inclusive of all taxes
You Save: 0. Discount 0%
Product is not available
FANID 40 TAB contains Famotidine 40 mg, a second-generation H2-receptor antagonist that reduces the production of stomach acid. It is used for treating active duodenal and gastric ulcers, gastroesophageal reflux disease (GERD), and other acid-related disorders. Manufactured by BluepillExpress, a leading pharmaceutical company in third-party production and global medicine export, FANID 40 TAB meets strict international manufacturing and quality benchmarks.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
FANID 40 TAB is an oral H2-receptor antagonist tablet that contains Famotidine 40 mg, designed to treat a variety of gastrointestinal conditions associated with excessive stomach acid. Famotidine works by blocking H2 receptors in the gastric parietal cells, effectively inhibiting the secretion of hydrochloric acid in response to stimuli like histamine, gastrin, or food intake.
This higher-dose formulation is especially effective in the short-term treatment of active duodenal or gastric ulcers, management of GERD, erosive esophagitis, and pathological hypersecretory conditions such as Zollinger-Ellison Syndrome. The 40 mg strength provides potent acid suppression, especially beneficial for night-time acid breakthrough or in severe cases.
Manufactured by BluepillExpress, FANID 40 TAB aligns with global standards, offering pharmaceutical partners and distributors a stable, trusted solution that can be customized under private label contracts. With a scalable and compliant manufacturing infrastructure, BluepillExpress supports global registrations and regulatory documentation.
Therapeutic Uses
Active duodenal and gastric ulcers
GERD (Gastroesophageal Reflux Disease)
Erosive esophagitis
Zollinger-Ellison Syndrome
NSAID-induced ulcers prevention
Stress ulcers prophylaxis in critically ill patients
Maintenance therapy after ulcer healing
Mechanism of Action
Famotidine, an H2-receptor blocker, selectively inhibits the action of histamine at H2 receptors in the stomach lining, thereby reducing both basal and stimulated gastric acid secretion. This leads to reduced acidity in the stomach, faster ulcer healing, and relief from acid reflux-related symptoms.
